Jan van Eys
- Hematology top 0.5%
- Acute Myeloid Leukemia Research 16
- Genetics top 1%
- Glioma Diagnosis and Treatment 18
-
- Childhood Cancer Survivors' Quality of Life 38
- Ethics and Legal Issues in Pediatric Healthcare 14
-
- Acute Lymphoblastic Leukemia research 19
- Neurology top 5%
-
- Enzyme function and inhibition 12
-
- Diet, Metabolism, and Disease 11
-
- Ethics in medical practice 9
Jan van Eys
156 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Hematology 1.3k
- Genetics 831
- Pediatrics, Perinatology and Child Health 1.0k
- Public Health, Environmental and Occupational Health 1.1k
- Neurology 378
Countries citing papers authored by Jan van Eys
This map shows the geographic impact of Jan van Eys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan van Eys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan van Eys more than expected).
Fields of papers citing papers by Jan van Eys
This network shows the impact of papers produced by Jan van Eys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan van Eys. The network helps show where Jan van Eys may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jan van Eys, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 26 | |
| 2 | 2006 | 40 | |
| 3 | 1997 | 68 | |
| 4 | 1994 | 44 | |
| 5 | 1992 | 67 | |
| 6 | 1991 | 46 | |
| 7 | 1989 | 20 | |
| 8 | 1989 | 29 | |
| 9 | 1989 | 324 | |
| 10 | 1988 | 10 | |
| 11 | 1988 | 33 | |
| 12 | Modern medicine and old dilemmas. | 1988 | 0 |
| 13 | Phase I trial of procarbazine as a 5-day continuous infusion in children with central nervous system tumors. | 1987 | 4 |
| 14 | 1986 | 30 | |
| 15 | Code of ethics for the University of Texas System Cancer Center M.D. Anderson Hospital and Tumor Institute. | 1985 | 3 |
| 16 | Effect of Nutritional Status on Response to Therapy | 1982 | 39 |
| 17 | 1979 | 2 | |
| 18 | The effect of L-ascorbic acid in vitro on lymphocyte reactivity to mitogens | 1979 | 1 |
| 19 | 1962 | 23 | |
| 20 | 1958 | 1 |
About Jan van Eys
Jan van Eys is a scholar working on Pediatrics, Perinatology and Child Health, Genetics and Hematology, having authored 160 papers that have together received 4.7k indexed citations. Recurring topics across this work include Childhood Cancer Survivors' Quality of Life (38 papers), Acute Lymphoblastic Leukemia research (19 papers), Glioma Diagnosis and Treatment (18 papers), Acute Myeloid Leukemia Research (16 papers), Ethics and Legal Issues in Pediatric Healthcare (14 papers), Enzyme function and inhibition (12 papers), Diet, Metabolism, and Disease (11 papers) and Ethics in medical practice (9 papers). The work is most often cited by research in Hematology (1.3k citations), Genetics (831 citations) and Pediatrics, Perinatology and Child Health (1.0k citations). Jan van Eys has collaborated with scholars based in United States, Canada and Norway. Frequent co-authors include Nathan O. Kaplan, Ayten Cangır, Yeu‐Ming Wang, Jeanette Pullen, Louis M. Aledort, Joseph C. Fratantoni, Jack Lazerson, Carol K. Kasper, Campbell W. McMillan and Peter H. Levine. Their work appears in journals such as Cancer, Journal of Biological Chemistry, Journal of Neuro-Oncology, Journal of Nutrition and Journal of Parenteral and Enteral Nutrition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.